The ongoing controlled clinical trials are expected to address the major questions concerning the indications and benefits of autologous HSCT in ADs, enabling the referral for transplantation ...

Among rheumatologic ADs, SS is the most common indication, but there is some doubt as to whether the interest in autologous HSCT has been elicited by distinctive features of the disease or by the ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with pediatric allogeneic ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.